NexImmune, Inc. (NEXI)
NEXI Stock Price Chart
Explore NexImmune, Inc. interactive price chart. Choose custom timeframes to analyze NEXI price movements and trends.
NEXI Company Profile
Discover essential business fundamentals and corporate details for NexImmune, Inc. (NEXI) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
12 Feb 2021
Employees
6.00
Website
https://www.neximmune.comCEO
John Trainer
Description
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials for the treatment of patients with acute myeloid leukemia; NEXI-002, an autologous cell therapy that is in Phase I/II clinical trials for the treatment of patients with relapsed and/or refractory in multiple myeloma; and NEXI-003, a candidate targeted against HPV-associated malignancies, which is in preclinical stage. NexImmune, Inc. was incorporated in 2011 and is headquartered in Gaithersburg, Maryland.
NEXI Financial Timeline
Browse a chronological timeline of NexImmune, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 5 Jun 2025
Earnings released on 29 May 2025
Earnings released on 27 Mar 2025
Earnings released on 26 Dec 2024
Earnings released on 7 Aug 2024
EPS came in at -$1.69 .
Earnings released on 16 Apr 2024
EPS came in at -$4.99 surpassing the estimated -$5.85 by +14.70%.
Earnings released on 7 Feb 2024
EPS came in at -$5.03 surpassing the estimated -$5.85 by +14.10%, while revenue for the quarter reached $2.12M .
Earnings released on 17 Nov 2023
EPS came in at -$9.40 falling short of the estimated -$7.50 by -25.33%.
Stock split effective on 19 Oct 2023
Shares were split 1 : 25 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 10 Aug 2023
EPS came in at -$7.25 matching the estimated -$7.25.
Earnings released on 15 May 2023
EPS came in at -$9.25 surpassing the estimated -$11.25 by +17.78%.
Earnings released on 28 Mar 2023
EPS came in at -$16.25 falling short of the estimated -$14.50 by -12.07%.
Earnings released on 14 Nov 2022
EPS came in at -$15.00 surpassing the estimated -$16.50 by +9.09%.
Earnings released on 15 Aug 2022
EPS came in at -$17.25 falling short of the estimated -$16.50 by -4.55%.
Earnings released on 12 May 2022
EPS came in at -$16.50 surpassing the estimated -$17.75 by +7.04%.
Earnings released on 9 Mar 2022
EPS came in at -$17.00 surpassing the estimated -$21.00 by +19.05%.
Earnings released on 12 Nov 2021
EPS came in at -$16.25 surpassing the estimated -$16.75 by +2.99%.
Earnings released on 9 Aug 2021
EPS came in at -$13.50 matching the estimated -$13.50.
Earnings released on 17 May 2021
EPS came in at -$17.75 surpassing the estimated -$20.25 by +12.35%.
Earnings released on 31 Mar 2021
EPS came in at -$8.11 .
Earnings released on 11 Feb 2021
EPS came in at -$13.32 .
NEXI Stock Performance
Access detailed NEXI performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.